Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3918

  • Filters activated: Field: Title/Abstract. Clear all
1.

Prognostic Utility of Oxygen-Sensitive Cardiac Magnetic Resonance Imaging in Diabetic and Nondiabetic Chronic Kidney Disease Patients With No Known Coronary Artery Disease.

Shah R, Parnham S, Liang Z, Perry R, Bradbrook C, Smith E, Faull R, Woodman RJ, Nucifora G, Gleadle JM, Selvanayagam JB.

JACC Cardiovasc Imaging. 2019 Feb 11. pii: S1936-878X(19)30047-6. doi: 10.1016/j.jcmg.2018.12.014. [Epub ahead of print] No abstract available.

PMID:
30772234
2.

Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease.

Tsujimoto T, Kajio H.

Int J Cardiol. 2019 Feb 7. pii: S0167-5273(18)37197-3. doi: 10.1016/j.ijcard.2019.02.008. [Epub ahead of print]

3.

Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre flash continuous glucose monitor (FSL-CGMS).

Hassanein M, Rashid F, Elsayed M, Basheir A, Al Saeed M, Abdelgadir E, AbuelKheir S, Khalifa A, Al Sayyah F, Bachet F, Jacob S, Alawadi F.

Diabetes Res Clin Pract. 2019 Feb 13. pii: S0168-8227(18)31597-3. doi: 10.1016/j.diabres.2019.01.038. [Epub ahead of print]

PMID:
30771364
4.

Effects of Dapagliflozin vs. Vildagliptin on Cardiometabolic Parameters in Diabetic Patients with Coronary Artery Disease: A Randomised Study.

Phrommintikul A, Wongcharoen W, Kumfu S, Jaiwongkam T, Gunaparn S, Chattipakorn SC, Chattipakorn N.

Br J Clin Pharmacol. 2019 Feb 14. doi: 10.1111/bcp.13903. [Epub ahead of print]

PMID:
30767253
5.

Glycaemic variability is associated with severity of coronary artery disease in patients with poorly controlled type 2 diabetes and acute myocardial infarction.

Benalia M, Zeller M, Mouhat B, Guenancia C, Yameogo V, Greco C, Yao H, Maza M, Vergès B, Cottin Y.

Diabetes Metab. 2019 Feb 11. pii: S1262-3636(19)30027-8. doi: 10.1016/j.diabet.2019.01.012. [Epub ahead of print]

PMID:
30763700
6.

Obstructive and non-obstructive coronary artery disease in long-lasting type 1 diabetes: a 7-year prospective cohort study.

Konduracka E, Cieślik G, Małecki MT, Gajos G, Siniarski A, Malinowski KP, Kostkiewicz M, Mastalerz L, Nessler J, Piwowarska W.

Pol Arch Intern Med. 2019 Feb 13. doi: 10.20452/pamw.4440. [Epub ahead of print]

7.

Association of Isoprostanes-Related Oxidative Stress with Vulnerability of Culprit Lesions in Diabetic Patients with Acute Coronary Syndrome.

Su G, Zhang T, Yang HX, Dai WL, Wang T, Tian L, Mi SH.

Int Heart J. 2019 Feb 8. doi: 10.1536/ihj.18-233. [Epub ahead of print]

8.

Relationships between blood pressure lowering therapy and cardiovascular events in hypertensive patients with coronary artery disease and type 2 diabetes mellitus: The HIJ-CREATE sub-study.

Kamishima K, Ogawa H, Jujo K, Yamaguchi J, Hagiwara N.

Diabetes Res Clin Pract. 2019 Feb 6;149:69-77. doi: 10.1016/j.diabres.2019.01.031. [Epub ahead of print]

PMID:
30735770
9.

Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome.

Gerbaud E, Darier R, Montaudon M, Beauvieux MC, Coffin-Boutreux C, Coste P, Douard H, Ouattara A, Catargi B.

Diabetes Care. 2019 Feb 6. pii: dc182047. doi: 10.2337/dc18-2047. [Epub ahead of print]

PMID:
30728222
10.

Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.

Adamek KE, Ramadurai D, Gunzburger E, Plomondon ME, Ho PM, Raghavan S.

J Am Heart Assoc. 2019 Feb 5;8(3):e011448. doi: 10.1161/JAHA.118.011448.

11.

Cardiovascular Risk in Mild to Moderately Decreased Glomerular Filtration Rate, Diabetes and Coronary Heart Disease in a Southern European Region.

Gil-Terrón N, Cerain-Herrero MJ, Subirana I, Rodríguez-Latre LM, Cunillera-Puértolas O, Mestre-Ferrer J, Grau M, Dégano IR, Elosua R, Marrugat J, Ramos R, Baena-Díez JM, Salvador-González B.

Rev Esp Cardiol (Engl Ed). 2019 Jan 29. pii: S1885-5857(18)30520-6. doi: 10.1016/j.rec.2018.12.006. [Epub ahead of print] English, Spanish.

PMID:
30709697
12.

ST-segment elevation myocardial infarction with non-obstructive coronary arteries in a patient with severe diabetic acidosis.

Mazur R, Buksińska-Lisik M, Mamcarz A.

Pol Merkur Lekarski. 2018 Dec 28;45(270):248-250.

PMID:
30693911
13.

Stress hyperglycemia: A prospective study examining the relationship between glucose, cortisol and diabetes in myocardial infarction.

Cheung NW, Wong KYC, Kovoor P, McLean M.

J Diabetes Complications. 2019 Jan 4. pii: S1056-8727(18)31063-8. doi: 10.1016/j.jdiacomp.2018.12.015. [Epub ahead of print]

PMID:
30691725
14.

Serum protein signature of coronary artery disease in type 2 diabetes mellitus.

Adela R, Reddy PNC, Ghosh TS, Aggarwal S, Yadav AK, Das B, Banerjee SK.

J Transl Med. 2019 Jan 24;17(1):17. doi: 10.1186/s12967-018-1755-5.

15.

Circulating microRNA-92a level predicts acute coronary syndrome in diabetic patients with coronary heart disease.

Wang W, Li Z, Zheng Y, Yan M, Cui Y, Jiang J.

Lipids Health Dis. 2019 Jan 22;18(1):22. doi: 10.1186/s12944-019-0964-0.

16.

Resveratrol Effects on a Diabetic Rat Model with Coronary Heart Disease.

Huo X, Zhang T, Meng Q, Li C, You B.

Med Sci Monit. 2019 Jan 18;25:540-546. doi: 10.12659/MSM.910996.

17.

Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015.

Read SH, Fischbacher CM, Colhoun HM, Gasevic D, Kerssens JJ, McAllister DA, Sattar N, Wild SH; Scottish Diabetes Research Network Epidemiology Group.

Diabetologia. 2019 Mar;62(3):418-425. doi: 10.1007/s00125-018-4796-7. Epub 2019 Jan 17.

PMID:
30656362
18.
19.

Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study.

Colaci M, Giuggioli D, Spinella A, Vacchi C, Lumetti F, Mattioli AV, Coppi F, Aiello V, Perticone M, Malatino L, Ferri C.

Clin Rheumatol. 2019 Jan 16. doi: 10.1007/s10067-019-04427-2. [Epub ahead of print]

PMID:
30649681
20.

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration.

Seferovic JP, Bentley-Lewis R, Claggett B, Diaz R, Gerstein HC, Køber LV, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Pfeffer MA.

J Diabetes Res. 2018 Dec 16;2018:1631263. doi: 10.1155/2018/1631263. eCollection 2018.

Supplemental Content

Loading ...
Support Center